Alpha-fetoprotein (AFP)-producing gastric cancer

Clinical trials for Alpha-fetoprotein (AFP)-producing gastric cancer explained in plain language.

Never miss a new study

Get alerted when new Alpha-fetoprotein (AFP)-producing gastric cancer trials appear

Sign up with your email to follow new studies for Alpha-fetoprotein (AFP)-producing gastric cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for advanced cancers? first human trial launches

Disease control Recruiting now

This early-stage study is testing a new drug called BGB-B2033, alone or with other drugs, in people with advanced liver, stomach, or lung cancers. The goal is to see if it is safe and how well it works. About 392 participants will take part.

Matched conditions: ALPHA-FETOPROTEIN (AFP)-PRODUCING GASTRIC CANCER

Phase 1/2 • Sponsor: BeOne Medicines • Aim: Disease control

Last updated Sep 18, 2026 00:00 UTC

Alpha-fetoprotein (AFP)-producing gastric cancer

Get alerted when new Alpha-fetoprotein (AFP)-producing gastric cancer trials appear

New hope for advanced cancers? first human trial launches